STARHS Symposium

The Ontario HIV Treatment Network is pleased to have sponsored a special symposium on Serological Testing Assays for the detection of Recent HIV Seroconversion (STARHS) held in conjunction with the AIDS 2006 Conference.

Presentations from the workshop:

Setting the Stage in epidemiology

  • slides video Epidemiology, Surveillance And Monitoring – Why distinguishing recent from past infection is important.
  • Chris Archibald
  • slides video Methodologic Issues – Using STARHS to assess incidence
  • Robert S. Remis

Setting the Stage in the laboratory

  • slides video Overview of the biology of acute HIV infection/basis of different approaches distinguishing recent from past HIVinfection
  • Elizabeth Dax

EXPERIENCE WITH BED AND OTHER METHODS

  • slides video 100 Are serological assays for recent infection effective to estimate HIV-1 incidence in Africa? [France]
  • C. Sakarovitch; F. Rouet; G. Murphy; A. Alioum; A. Minga; B. Liandier; T.D. Toni; F. Dabis; D. Costagliola; R. Salamon; J. Parry; F. Barin
  • slides video 101 Comparison of two assays for identifying incident infection among cases of newly diagnosed HIV infection [Australia]
  • Ann M. McDonald; Philip Cunningham; Anthony Kelleher; John M. Kaldor
  • slides video 102 HIV-1 incidence studied by the IgG capture BED enzyme immunoassay in IDU population of China [China]
  • Yan Jiang; Yao Xiao; Jigang Feng; Wenyan Xu; Minjie Wang
  • 103 Preparing for BED incidence testing: assessing the quality of HIV surveillance testing in Thailand [Thailand]
  • W. Chalermchan; A. Sriburi; P. Unpol; S. Nookhai; V. Pobkeeree; T. Plipat; B. Parekh; K. Fox; J. Tappero; P. Sawanpanyalert
  • slides video 104 A simple and inexpensive particle agglutination test to distinguish recent and established HIV-1 infection [USA]
  • Niel T. Constantine; Hong Li; Fassil Ketema; Anne M. Sill; Kristen M. Kreise; Farley R. Cleghorn
  • slides video 105 Recency assessment in newly diagnosed HIV-1 infections by means of a standardized line immunoassay used for HIV-1/2 confirmation [Switzerland]
  • Jörg Schüpbach; Martin Gebhardt; Christoph Niederhauser; Luc Perrin; Philippe Bürgisser; Lukas Matter; Meri Gorgievski; Rolf Dubs; Detlev Schultze; Peter Erb; Corinne Andreutti; Jean-Claude Piffaretti; B. Guentert; Roger Staub; Synove Daneel; Pietro Vernazza
  • slides video 106 HIV-1 incidence in blood donors in France between 1992 and 2004: Use of an immunoassay to identify recent infections [France]
  • Josiane Pillonel; Francis Barin; Syria Laperche; Pascale Bernillon; Stéphane Le Vu1; Benoît Liandier; Georges Andreu; Jean-Claude Desenclos
  • slides video 107 Incidence testing of HIV cases by Calypte BED Assay using dried blood spots from a high prevalent district in the State of Andhra Pradesh, South India [India]
  • V. Lakshmi; T.Sudha Rani; Bhanu Rekha; Lalit Dandona
  • slides video 108 Comparison of three methods to detect recent HIV 1 infection in specimens collected cross-sectionally in a cohort of female sex workers in the Dominican Republic [USA]
  • S.B. Gupta; E. Koenig; G.Murphy; C.Adon; C Beyrer; S.Khawaja; J.Parry; W.Straus

OVERCOMING THE PROBLEMS

  • slides video 200 Serological testing algorithm for recent HIV seroconversion (STARHS) identifies a high and increasing proportion of newly diagnosed individuals as recently infected [UK]
  • D. Pao; M. Fisher; G. Dean; G. Murphy; J. Parry
  • slides video 201 Examination of avidity in STARHS testing for HIV incidence [Canada]
  • Y. Adonsu-Hoyi; B. Calder-Kent; L. Malloch; C. Archibald; P. Sandstrom; J. Kim
  • slides video 202 Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay [Zimbabwe]
  • John Hargrove; Jean Humphrey; Kuda Mutasa; Bharat Parekh; Steve McDougal; Robert Ntozini; Henry Chidawanyika; Brian Ward; Kusum Nathoo; Peter Iliff; Ekkehard Kopp; The ZVITAMBO Study Group
  • slides video 203 The effect of viral suppression on cross sectional incidence testing: The 2001 Johns Hopkins Hospital Emergency Department sero-survey as an example [USA]
  • Oliver B. Laeyendecker; Charlamaine Henson; S. Michele Owen; Bobbi Jo Horne; Richard E. Rothman; Gabor.D. Kelen; Kerunne S. Ketlogetswe; Judy. Shahan; Renu Lal; Thomas C. Quinn
  • slides video 204 HIV incidence estimates: South Africa 2005 [South Africa]
  • Thomas Rehle, Victoria Pillay; Adrian Puren; Olive Shisana
  • slides video 205 The effect of confounding factors on the specificity of tests employed in the serological testing algorithm for recent HIV seroconversion (STARHS) [UK]
  • G. Murphy; G. Dean; M. Fisher; D. Pao; D. McElborough; H. Munro; O.N. Gill; J.V. Parry
  • slides video 206 Proficiency testing program for HIV-1 BED incidence assay: summary of pilot round of results [USA]
  • Xin Liu; Bharat Parekh

Validating Of New STARHS Assays:

  • slides video Laboratory And Epidemiological Aspects
  • Bernard Branson

Exploring Horizons Beyond HIV

  • slides video Recent Application Of Serological And NAT Strategies For Cross-Sectional Incidence Studies Of HIV And HCV Infections In High Risk And Blood Donor Populations
  • Michael Busch
  • slides video Exploring Horizons Beyond HIV
  • John Parry
  • slides video 300 A call for the development of epidemiologically relevant STI testing strategies for a population relevant methodology that measures sexual behaviour and HIV-1 risk based on biological markers [Canada]
  • S.K. Sgaier; N. Negalkerke; A. Kalaichandran; L. Chen; P. Milson; P. Arora; P. Jha

9 out of 10 Ontarians agree that Ontario needs new options for HIV/AIDS health care services that will reduce patient hospital stays